12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer

Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) aren't the only mRNA coronavirus vaccine makers in town. In fact, another company has been gaining ground -- and reported pivotal trial results this week. I'm talking about German biotech CureVac (NASDAQ:CVAC).